At what age should Dual-Energy X-ray Absorptiometry (DEXA) scans be initiated in females?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DEXA Scan Screening Age for Females

All women should begin routine DEXA screening at age 65 years, regardless of risk factors. 1, 2, 3

Standard Screening Age

  • Women aged 65 years and older require routine DEXA screening without any additional risk assessment. 1, 2, 3
  • The US Preventive Services Task Force, American College of Obstetricians and Gynecologists, and American Academy of Family Physicians all consistently recommend universal screening beginning at age 65. 1, 2, 3
  • Women younger than 65 years should not receive routine screening unless they meet specific high-risk criteria. 2, 3

Earlier Screening for High-Risk Women Under Age 65

Postmenopausal women younger than 65 years should undergo DEXA screening only if they have elevated fracture risk based on clinical assessment. 1, 2

Specific High-Risk Criteria Requiring Earlier Screening:

  • History of fragility fracture (fracture from minimal trauma) 1, 2, 3
  • Body weight less than 127 pounds (58 kg) 1
  • Parental history of hip fracture 1
  • Long-term glucocorticoid therapy (≥5 mg prednisone daily for ≥3 months) 1, 2, 3
  • Medical conditions causing bone loss: hyperparathyroidism, hypogonadism, premature menopause, chronic inflammatory diseases, malabsorption disorders 1, 2, 3
  • Medications associated with bone loss (beyond glucocorticoids) 1, 2, 3
  • Chronic alcoholism 3
  • Early hysterectomy (particularly if it resulted in premature estrogen deficiency) 4

Risk Assessment Tools for Women Under 65:

  • The FRAX calculator can help identify postmenopausal women under 65 who warrant screening. 1, 2, 3
  • A 10-year major osteoporotic fracture risk of ≥9.3% (equivalent to a 65-year-old white woman with normal BMI and no risk factors) suggests screening is appropriate. 1, 2
  • Alternative tools include OST (Osteoporosis Self-Assessment Tool) and ORAI (Osteoporosis Risk Assessment Instrument) for identifying women who need DEXA. 1

Critical Pitfalls to Avoid

  • Do not delay screening in high-risk women until age 65 when clear risk factors are present, as significant bone loss and fractures can occur earlier. 2, 3
  • Do not screen women under 65 without documented risk factors, as this exposes them to unnecessary testing and potential overtreatment. 2, 3
  • Do not assume obesity protects against osteoporosis when other major risk factors (such as alcoholism or glucocorticoid use) are present. 3
  • Do not repeat DEXA scans more frequently than every 2 years in low-risk individuals, as the precision of testing requires this minimum interval to detect meaningful change. 2, 5

Screening Intervals After Initial DEXA

  • For women with normal bone density (T-score ≥ -1.0), repeat screening in 2-3 years or longer depending on baseline values. 2
  • For women with osteopenia (T-score between -1.0 and -2.5), repeat in 2-3 years unless baseline T-score is less than -2.0. 2
  • For women with osteoporosis or on treatment, repeat in 1-2 years to monitor treatment response. 2, 3
  • Women with normal BMD at age 65 may not require repeat testing for up to 17 years, as transition to osteoporosis occurs very slowly in this population. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

DEXA Scan Guidelines for Osteoporosis Screening

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

DEXA Scan Indications for Osteoporosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Osteoporosis Screening Guidelines for High-Risk Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Ontario health technology assessment series, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.